Healthcare provider profile · identity verified

James Robert Powell, M.D.

Internal Medicine · GREENVILLE, NC · NPI 1366479370

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	422	146
Atorvastatin Calcium	Atorvastatin Calcium	339	129
Gabapentin	Gabapentin	234	71
Losartan Potassium	Losartan Potassium	175	69
Eliquis	Apixaban	161	30
Lisinopril	Lisinopril	153	60
Omeprazole	Omeprazole	126	40
Levothyroxine Sodium	Levothyroxine Sodium	123	40
Duloxetine Hcl	Duloxetine Hcl	117	33
Pantoprazole Sodium	Pantoprazole Sodium	117	40
Albuterol Sulfate Hfa	Albuterol Sulfate	110	48
Furosemide	Furosemide	108	44
Hydrochlorothiazide	Hydrochlorothiazide	100	44
Carvedilol	Carvedilol	98	39
Warfarin Sodium	Warfarin Sodium	93	33
Metformin Hcl	Metformin Hcl	92	37
Metoprolol Succinate	Metoprolol Succinate	90	31
Fluticasone Propionate	Fluticasone Propionate	82	35
Trazodone Hcl	Trazodone Hcl	79	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	32
Tamsulosin Hcl	Tamsulosin Hcl	76	27
Metoprolol Tartrate	Metoprolol Tartrate	74	26
Ozempic	Semaglutide	73	24
Pravastatin Sodium	Pravastatin Sodium	73	27
Jardiance	Empagliflozin	70	20
Simvastatin	Simvastatin	70	19
Sertraline Hcl	Sertraline Hcl	62	22
Famotidine	Famotidine	61	19
Hydralazine Hcl	Hydralazine Hcl	59	16
Montelukast Sodium	Montelukast Sodium	59	20
Chlorthalidone	Chlorthalidone	58	18
Spironolactone	Spironolactone	58	21
Metformin Hcl Er	Metformin Hcl	57	26
Alendronate Sodium	Alendronate Sodium	55	15
Colchicine	Colchicine	54	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	20
Rosuvastatin Calcium	Rosuvastatin Calcium	52	21
Diclofenac Sodium	Diclofenac Sodium	51	16
Prednisone	Prednisone	50	20
Valsartan	Valsartan	48	20
Mirtazapine	Mirtazapine	47	16
Potassium Chloride	Potassium Chloride	47	21
Clopidogrel	Clopidogrel Bisulfate	46	15
Entresto	Sacubitril/Valsartan	43	suppressed
Ezetimibe	Ezetimibe	43	15
Januvia	Sitagliptin Phosphate	42	11
Trulicity	Dulaglutide	42	11
Ventolin Hfa	Albuterol Sulfate	41	11
Allopurinol	Allopurinol	39	17
Escitalopram Oxalate	Escitalopram Oxalate	39	11
Finasteride	Finasteride	39	12
Bumetanide	Bumetanide	38	15
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Humalog Kwikpen U-100	Insulin Lispro	36	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	13
Nitroglycerin	Nitroglycerin	32	11
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	12
Pregabalin	Pregabalin	31	13
Baclofen	Baclofen	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	11
Levetiracetam	Levetiracetam	28	11
Meclizine Hcl	Meclizine Hcl	27	13
Spiriva Handihaler	Tiotropium Bromide	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Glipizide	Glipizide	24	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	11
Azelastine Hcl	Azelastine Hcl	23	13
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Clonazepam	Clonazepam	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Naproxen	Naproxen	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Primidone	Primidone	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Irbesartan	Irbesartan	14	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Topiramate	Topiramate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Ondansetron Odt	Ondansetron	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Mexiletine Hcl	Mexiletine Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error